Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Long Term Effects of Chemotherapy Tracy Sarin, ARNP Definition • Late effects: side effects that occur months to years after treatment • Issues arise from surgery, radiation, and chemotherapy Who and Why • Multidisciplinary • • • • • Primary care providers Hematology/oncology Nursing Physical and/or occupational therapy Mental health professional • 2006 IOM report: From Cancer Patient to Cancer Survivor: Lost in Translation Cancer Statistics • In 2014, nearly 14.5 million Americans with a history of cancer were alive (DeSantis, et al, 2014) Men Prostate (43%) Colorectal (9%) Melanoma (8%) Women Breast (43%) Endometrial (8%) Colorectal (8%) • By 2024, population of cancer survivors will increase to approximately 19 million people (DeSantis, et al, 2014) Virtually Every System is Affected Head and Neck • Brain/CNS • • • • Hearing changes Cognitive impairment Memory issues Peripheral neuropathy • Eye • Cataracts • Vision change • Oral health/Dental • Decreased tooth enamel • Osteonecrosis of the jaw Head and Neck • Offending agents • • • • • • • • • Vinca alkaloids (vincristine) Platinums (carbo, cis, oxali Taxanes (paclitaxel, docetaxel) Etoposide Cytarabine—high dose Ifosfamide—high dose Methotrexate—high dose Steroids Bisphosphonates Cardiovascular • • • • CHF Hypertension MI DVT • Particularly with hormone treatment • Edema • Hyperlipidemia • Cardiomyopathy • Biggest offenders • Anthracyclines and HER2 targeted drugs (doxorubicin, daunorubicin, traztuzumab, pertuzumab, etc) Pulmonary • • • • Shortness of breath Decreased lung capacity Pulmonary fibrosis Interstitial lung disease • Offending agents • • • • • Bleomycin (most common)—10% Carmustine (BCNU) – 20-30% of those getting high dose therapy Methotrexate – 8% Alkylating agents (cyclophosphamide, busulfan) - <1% ????? Immunotherapy agents (nivolumab, pembrolizumab, ipilimumab)????????---stay tuned GI/GU • • • • Digestion Neuropathy in gut Chronic bowel changes Bladder cystitis • Offending chemotherapies • • • • Vinca alkaloids (vincristine) Cyclophosphamide Ifosfamide Platinums (carboplatin, oxaliplatin, cisplatin) Endocrine • • • • • • • • • Menopause/ovarian failure Infertility Weight gain Decreased libido Erectile dysfunction Hormone deprivation in men Diabetes Thyroid dysfunction Hot flashes Endocrine • Treatment causes • • • • • • • • • • • Busulfan Chlorambucil Cisplatin Cyclophosphamide Nitrogen mustard Tamoxifen Aromatase inhibitors (anastarzole, exemestane, letrozole) Bicalutamide Leuprolide Steroids Ipilumumab Musculoskeletal • • • • • Osteoporosis Osteopenia Increased risk of fracture Arthralgias Myalgias • Offending agents • Hormone therapy (aromatase inhibitors) • Steroids • Chemotherapies inducing menopause Skin • • • • • Nail changes Dry skin Skin discoloration Sun sensitivity Radiation recall • Offenders • • • • • • Taxanes 5FU Cyclophosphamide Doxorubicin Hydroxyurea BRAF inhibitors used in melanoma Bone Marrow/Secondary Cancers • Cytopenias • MDS • Secondary cancer • • • • 1-3% of patients develop a new, secondary cancer Rate is higher in pediatric cancer survivors ALL in kids--secondary AML Colorectal cancer--secondary colon/retctal primary or other digestive organs • Lung—secondary lung, head/neck, and GU • Melanoma—additional skin cancers • Causative agents: doxorubicin,BCNU, ifosfamide, cytoxan, melphalan, etc. Emotional • • • • • • • Depression Anxiety Mood swings Guilt Fear of recurrence Post-traumatic stress disorder Gratitude • Financial implications of chemotherapy FATIGUE • Most common side effect of cancer treatment • Offending agents: ALL chemotherapy/hormone therapy/biotherapy/immunotherapy What to do, what to do • Brain/CNS • • • • • Hearing changes—audiology referral Eye issues— ophthalmology referral, cataract surgery Oral/dental— diligent dental care Chemobrain—patience, CBT, neuropsych referral Peripheral neuropathy • Assess for functional impairment • Patience • Medication management: gabapentin, pregabalin, duloxetine, amitriptyline, opioids • PT referral • Neurology referral Cardiovascular • Monitoring • Check EF during treatment with cardiotoxic drugs • CHF—swelling, SOA • DVT—doppler if indicated (particularly in those on hormone therapy) • Heart disease/hyperlipidemia Pulmonary • Surveillance/monitoring • Lung disease—refer to pulmonary or managed by PCP • Immunotherapy—treat with steroids and taper GI/GU • Digestion • Constipation—fiber/laxatives, GI referral • Diarrhea—loperamide, diphenoxylate with atropine, codeine, cholestyramine, GI referral • Neuropathy—motility agents, GI referral • Bladder cystitis • Urology referral Endocrine • Proactivity/counseling for fertility issues • AYA program, referral for banking • Women’s health issues • Menopause/ovarian failure/dryness/hot flashes • Avoid herbs/supplements and hormone replacement therapy • Lubricants • Assessment of hot flashes • Venlafaxine, gabapentin, clonidine • Weight gain • Exercise, referral to dietitian, support groups • DM/thyroid • PCP or endocrinologist Musculoskeletal • Bone density testing • Ca++ with vitamin D • Weight bearing exercise • Assistive device if needed, SAFETY FIRST • PT referral • Bisphosphonates Skin • Emollients • Protection • Avoidance • Sunscreen • Cover • Surveillance by PCP • Dermatology referral Cytopenias/Secondary cancers • Investigation • Anemia, thrombocytopenia, leukopenia • BMBX necessary? • Encourage followup • Follow screening guidelines Emotional • Referral • Counseling • Support groups • Medication management • Antidepressants • Antianxiety medications • Financial • Financial counselor Fatigue • Exercise • PATIENCE • Treat underlying causes • Anemia • Thyroid conditions • Vitamin D deficiency • Energy conservation • Prioritize activities • Dietary modifications Case Study Conclusion • Population of cancer survivors will only grow • ASSESS, ASSESS, ASSESS • Treat or refer References • Cancer.Net. (2016). Long-term side effects of cancer treatment. Retrieved August, 2016, http://www.cancer.net/survivorshiplong-term-side-effects-cancer-treatment • DeSantis, C., Lin, C., Mariotto, A., Siegel, R., et al. (2014). Cancer treatment and survivorship statistics, 2014. CA: A Cancer Journal for Clinicians, 252-271. • MDAnderson Cancer Center. (2016). Possible side effects of cancer treatment. Retrieved, August, 2016, https://www.mdanderson.org/patients-family/life-aftercancer/long-term-effects.html • Mayo Clinic. (2016). Cancer survivors: Late effects of cancer treatment. Retrieved August, 2016, http://www.mayoclinic.org/diseases-conditions/cancer/indepth/cancer-survivor/art-20045524 • Oncology Nursing Society. (2014). Red flags in caring for cancer survivors. Retrieved August, 2016, https://www.ons.org/sites/default/files/media/Red%20Flags%20for%20Cancer%20Su rvivors.pdf • Up to Date. (2016). Long term side effects of chemotherapy. Retrieved August, 2016, https://www.uptodate.com/contents/search?search=long%20term%20side%20effect s%20of%20chemotherapy&sp=0&searchType=PLAIN_TEXT&source=USER_INPUT&se archControl=TOP_PULLDOWN&searchOffset=1&autoComplete=false&language=en& max=10